FULC·359616109·US·equity·Healthcare - Biotechnology-13D/G
FULC (FULCRUM THERAPEUTICS INC) is held by 95 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($46.4M), BlackRock, Inc. ($41.3M), Aberdeen Group plc ($17M). Net institutional sentiment: Mixed.
See how FULC's score breaks down across 4 SEC sources
Showing 1-20 of 106
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer